Contents

Current Cancer Therapy Reviews, Volume 2 - Number 2

Human T-Cell Leukemia Virus Type 1: Transition from Latent Infection to Pathogenic Progression and Implications for Molecular Therapy

, 2(2): 101 - 113

Yulia Tabakin-Fix, Inbal Azran-Shaish, Yana Schavinsky-Khrapunsky, Rachel Chamias, Lilach Gohari, Mahmoud Huleihel, Min Li-Weber and Mordechai Aboud


DOI: 10.2174/157339406776872843




Role of NF-κB and NF-κB-regulated Gene Products in Chemoresistance and Radioresistance

, 2(2): 115 - 125

Gautam Sethi and Bharat B. Aggarwal


DOI: 10.2174/157339406776872834




Epigenetic Therapies of Cancer

, 2(2): 127 - 135

Yasmin Bootwala and Debdutta Bandyopadhyay


DOI: 10.2174/157339406776872816




Genetic Polymorphisms of Drug Metabolising Enzymes and Drug Transporters in Relation to Cancer Risk

, 2(2): 137 - 155

Tessa M. Bosch, Irma Meijerman, Jos H. Beijnen and Jan H.M. Schellens


DOI: 10.2174/157339406776872825




The Insulin-Like Growth Factor (IGF) Signaling Pathway: Strategies for Successful Therapeutic Tasks in Cancer Treatment

, 2(2): 157 - 167

Kai Breuhahn, Tanja Nussbaum, Stephan Singer and Peter Schirmacher


DOI: 10.2174/157339406776872861




Treatment Strategies for Multiple Myeloma in the Age of Novel Therapies

, 2(2): 169 - 183

Laurence Catley and Kenneth C. Anderson


DOI: 10.2174/157339406776872807




Mechanism of Action and Therapeutic Potential of Novel Adamantyl Retinoid-Related Molecules

, 2(2): 185 - 198

F. J. Piedrafita and Maria A. Ortiz


DOI: 10.2174/157339406776872852




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science